Back to Search
Start Over
Stereotactic Body Radiation Therapy (SBRT) in Hepatocellular Carcinoma
- Source :
- Current Hepatology Reports. 20:12-22
- Publication Year :
- 2021
- Publisher :
- Springer Science and Business Media LLC, 2021.
-
Abstract
- Purpose of Review Hepatocellular carcinoma (HCC) is a rising cause of mortality and morbidity, and although surgical resection is the preferred curative local therapy, Recent Findings Multiple retrospective and prospective studies demonstrate that stereotactic body radiation therapy (SBRT) is an effective bridge for transplant candidates and local therapy for patients with inoperable early-, intermediate-, or advanced-stage disease. SBRT is associated with excellent local control, and it is well-tolerated despite study cohorts enriched with patients who failed prior therapies and had poor baseline liver function. Summary Additional randomized control trials are needed to determine the ideal treatment regimen and patient selection for SBRT.
- Subjects :
- medicine.medical_specialty
Hepatology
Treatment regimen
business.industry
Stereotactic body radiation therapy
Disease
medicine.disease
law.invention
03 medical and health sciences
0302 clinical medicine
Randomized controlled trial
law
030220 oncology & carcinogenesis
Virology
Hepatocellular carcinoma
Internal medicine
medicine
030211 gastroenterology & hepatology
Radiology
Liver function
business
Prospective cohort study
Subjects
Details
- ISSN :
- 21959595
- Volume :
- 20
- Database :
- OpenAIRE
- Journal :
- Current Hepatology Reports
- Accession number :
- edsair.doi...........1fcbe0fe7d65e65601a053016eb1bf1e